http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2020245434-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0128b1ea25bace77f9ff5dc6b2210d7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-0816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
filingDate 2020-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73dbeddb5eed70635c016fa51e04363c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca8d1c1a3dd3876ea0400b4a7bfb3e36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f048c1f67bc0ba5fb1b1051f4ed49bc6
publicationDate 2021-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2020245434-A1
titleOfInvention Pharmaceutical compounds for the treatment of complement mediated disorders
abstract This disclosure provides pharmaceutical compounds to treat medical disorders, such as complement-mediated disorders, including complement Cl -mediated disorders.
priorityDate 2019-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467986124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467407281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465296303
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465144500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163552797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467968317

Total number of triples: 38.